The failure to follow good manufacturing practices leads to product defects, contamination, and other problems that put patients at risk.
List of drugs that "when medically needed in acute care must be available and used within hours or days of the need or the patient may suffer serious outcomes which may include disability or death." Check the dashboards for the most recent shortages, or at the complete PDF list, updated every week.
Get Resilient Drug Supply updates in your inbox.
Pfizer said it would continue to fill orders of products for which it has inventory at 100% of historical levels, although there may be local disruptions.
Incentives for manufacturers and hospitals, and a buffer inventory, are needed, a new report says.
Reducing dependencies on foreign countries will be complicated.
Shortages of two drugs—cisplatin and carboplatin—are dire enough that the FDA is working with a Chinese manufacturer and a Canadian drugmaker on importing alternatives.
The resolution urges WHO member states to build national and subnational systems to ensure uninterrupted access to medical oxygen to healthcare facilities in both urban and rural areas.
Regulators, pharmacists, and healthcare providers are alarmed by the trend.
Problems that have plagued the healthcare industry for years won't go away with the end of the COVID-19 public health emergency.
The drug has no therapeutic equivalents, meaning that some prostate cancer patients have been unable to secure their only treatment option.
All but 3 of these drugs are on the Resilient Drug Supply Project's (RDSP's) Critical Acute and COVID-19 Drug List.
Legislators have asked the FDA commissioner to answer questions by today on such issues as the country of origin for the manufacture and processing of each drug in shortage.
